Medical implants are devices that are utilized to replace or function as a portion of a biological structure or a specific bodily component. Thousands of individuals improve their quality of life each year by undergoing surgical procedures that entail the implantation or removal of implanted medical devices. Implants are now employed for a variety of purposes in the body, including orthopedics, pacemakers, cardiovascular stents, defibrillators, neurological prostheses, and medication delivery systems. Implants are surgically or medically implanted into the human body, either entirely or partly. Depending on the situation, the device can be implanted permanently or temporarily, and it may be withdrawn afterward. There has been an increase in the number of age-related illnesses as people's lifespans have increased. This has raised demand for life-extension medical aids such as novel therapies, implants, prostheses, and long-term pharmacological use. Tissues, metals, bones, polymers, skin, ceramics, and other materials are used to make implantable devices.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Cosmetic procedures are becoming more prevalent, fueled by a considerable rise in public interest in body aesthetics and physical attractiveness, fueling demand for implanted medical devices. Furthermore, advancements in technology that allow a person to improve his or her appearance, such as dental implants, pectoral implants, deltoid implants, thigh augmentation, breast implants, cochlear implants, and other devices, have led to the increased demand for these gadgets. Additionally, the increased prevalence of chronic conditions such as heart failures, arthritis, motor, sensory, or cognitive modalities, and others that necessitate various types of implants to prolong a patient's life are positively impacting market growth. Furthermore, a growth in the elderly population in both established and emerging nations has led in a growth in the incidence of numerous chronic illnesses, driving up demand for these goods even more.
In October 2019, NeuroRecovery Technologies combined with GTX Medical developed two technologies for patients with spinal cord injuries: Targeted Epidural Spine Stimulation (TESS), a spinal cord implant that provides real-time motion feedback, and Transcutaneous Spinal Cord Stimulation (tSCS). GTX medical BV is the new name for the merging company.
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Select License Type
US : +1 (716) 218-3733
UK : +44 (208) 1235555
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT